Personalis
Robert Moran has over 25 years of work experience in various roles and positions. Robert is currently the Director of Biopharma Business Development & Alliances at Personalis, Inc. Prior to that, they served as the Director of Pharma CDx Business Development at Invitae. From 2018 to 2021, Robert worked as the Director of Global Strategic Accounts at 10X Genomics. Robert also held the position of Director of Key Accounts and Distribution at Danaher Corporation from 2014 to 2018. Before that, they worked as the Senior Director of Key Accounts at MKS Instruments in 2013. From 2005 to 2013, Robert was the Director of Global Strategic Accounts at Veeco Instruments. Robert started their career as a Key Account Manager at Oerlikon in 2002 and served as the Director of Engineering Operations at LogiGear Corporation from 2000 to 2002. Robert began their professional journey as a Project Manager at Unaxis in 1995.
Robert Moran attended San Francisco State University, where they studied Physics with a focus on Astrophysics. Robert has also obtained various certifications in account management, executive speaking, finance and accounting, customer handling, large account management, selling, and strategic account management. The specific dates of obtaining the certifications are not provided.
Personalis
4 followers
Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.